Biochimica et Biophysica Acta-Reviews on Cancer

Papers
(The H4-Index of Biochimica et Biophysica Acta-Reviews on Cancer is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
A digital highway for data fluidity and data equity in precision medicine262
Histone deacetylase complexes: Structure, regulation and function213
Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients194
PAK2 as a therapeutic target in cancer: Mechanisms, challenges, and future perspectives190
Research progress of mitochondria and cytoskeleton crosstalk in tumour development173
Immunotherapy for HPV negative head and neck squamous cell carcinoma130
SENP3: Cancers and diseases129
The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity105
Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma103
Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights101
New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer87
Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy81
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy77
T cell exhaustion in human cancers77
New advances in the therapeutic strategy of head and neck squamous cell carcinoma: A review of latest therapies and cutting-edge research76
Retraction notice to “Coagulation and inflammation in cancer: Limitations and prospects for treatment” [Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877 (2022) 188727]75
A comprehensive review of current therapeutic strategies in cancers targeting DNA damage response mechanisms in head and neck squamous cell cancer75
Adipose tissue-to-breast cancer crosstalk: Comprehensive insights69
A Darwinian perspective on tumor immune evasion65
Editorial Board61
Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy58
The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate58
The role of m6A modification in pediatric cancer57
Machine Learning in Epigenomics: Insights into Cancer Biology and Medicine54
Emerging roles of PIWI-interacting RNAs (piRNAs) and PIWI proteins in head and neck cancer and their potential clinical implications53
Improving DCIS diagnosis and predictive outcome by applying artificial intelligence52
Ponatinib: An update on its drug targets, therapeutic potential and safety49
Extrachromosomal DNA: Redefining the pathogenesis of glioblastoma49
The potential of methioninase for cancer treatment46
Ezrin gone rogue in cancer progression and metastasis: An enticing therapeutic target46
A special subtype: Revealing the potential intervention and great value of KRAS wildtype pancreatic cancer44
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective42
Editorial Board42
Cancer stem cell in prostate cancer progression, metastasis and therapy resistance41
Mitochondrial dynamics, a new therapeutic target for Triple Negative Breast Cancer41
Recent advances in understanding the molecular role of phosphoinositide-specific phospholipase C gamma 1 as an emerging onco-driver and novel therapeutic target in human carcinogenesis40
Spatiotemporal heterogeneity and clinical challenge of pancreatic neuroendocrine tumors40
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?39
Targeting protein kinases benefits cancer immunotherapy38
The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics38
0.12331795692444